• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

lung cancer

Stop sign and red lights at traffic intersection
Pharma

Tagrisso rival loses EU approval after AZ legal challenge

EU regulators revoked Aumseqa’s approval after the EMA ruled that Hansoh’s application illegally referenced AstraZeneca’s Tagrisso.
Angus Liu Sep 30, 2026 11:13am
Enhertu

Increased deaths shadow Enhertu’s first-line lung cancer data

Sep 13, 2026 7:00pm
dart board miss failure

Failed Trodelvy first-line NSCLC trial shows better China data

Sep 12, 2026 9:45pm
Goal

Akeso, Summit’s ivonescimab hits OS goal in Keytruda head-to-head

Sep 3, 2026 10:29am
lung

Biokin, BMS' bispecific ADC hits goal in China lung cancer trial

Aug 18, 2026 11:18am
Podcast
Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b

GSK’s first lung cancer approval, a new IPO path and more

Jul 24, 2026 9:42am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings